Latest News about TAK
Recent news which mentions TAK
From Benzinga
With Approval For Dengue Vaccine, Takeda May Find It Challenging To Compete Bigger Rivals: Report
August 30, 2022
From Benzinga
From Benzinga
From Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 22, 2022
From Benzinga
Peering Into Takeda Pharmaceutical's Recent Short Interest
August 08, 2022
Tickers
TAK
From Benzinga
EXCLUSIVE: Takeda's Cancer Partner BridGene Raises $38.5M To Accelerate Work On Undruggable Targets
July 27, 2022
From Benzinga
Novavax's COVID-19 Vaccine Gets Back To Back Approval In Japan, Australia For Adolescents
July 26, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
What's Winning in 2022? 3 Stocks That Are Doing Fine
July 16, 2022
From Motley Fool
2 Best High-Yield Dividend Stocks to Buy Right Now
July 11, 2022
From Motley Fool
From Benzinga
From Motley Fool
Quant Ratings Updated on 66 Stocks
June 06, 2022
From InvestorPlace
From Motley Fool
From Benzinga
From Motley Fool
Takeda's Maribavir Reduces Hospitalization Rates, Hospital Stay In Post-Transplant Infection Patients
April 22, 2022
From Benzinga
From InvestorPlace
Why Nektar Therapeutics Stock Is Crashing Today
April 18, 2022
From Motley Fool
From Benzinga
Phathom Pharma's Vonoprazan Commercial Preparation Update At Needham Healthcare Conference
April 13, 2022
From Benzinga
From Benzinga
From Benzinga
Roche And AstraZeneca Settle Ultomiris Patent Lawsuit
February 22, 2022
From Benzinga
Takeda Inks $2B Gene Therapy Pact With Code Biotherapeutics
February 22, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.